San Diego, CA, United States of America

Rachel A Adams

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Locanabio, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rachel A Adams. Retrieved from https://idiyas.com/inventor/rachel-a-adams

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rachel A. Adams: Innovator in Engineered RNA Technologies

Introduction

Rachel A. Adams is a prominent inventor based in San Diego, California. With her groundbreaking contributions to the field of molecular biology, she has secured a patent for her innovative work on engineered short nuclear RNA (snRNA) systems.

Latest Patents

Rachel holds a patent titled "Compositions and methods comprising engineered short nuclear RNA (snRNA)," which focuses on snRNA systems that contain engineered stem loops. This invention marks a significant advancement in the understanding and application of RNA technologies.

Career Highlights

Currently, Rachel is a key player at Locanabio, Inc., a company dedicated to developing transformative RNA-targeted therapies. Her expertise and innovative mindset contribute to the company's mission of advancing therapeutic solutions through RNA technologies.

Collaborations

Throughout her career, Rachel has collaborated with talented individuals such as Rea Lardelli Markmiller and Ranjan Batra. These collaborations have allowed her to enhance her research and stay at the forefront of innovation in her field.

Conclusion

Rachel A. Adams continues to make remarkable strides in RNA research and technology. Her patent and ongoing work at Locanabio, Inc. exemplify her dedication to advancing science and developing innovative solutions for complex biological challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…